Eris Lifesciences Limited (NSE:ERIS)
India · Delayed Price · Currency is INR 1,473.90
-3.20 (-0.22%)
Jan 14, 2026, 3:29 PM IST
Eris Lifesciences Market Cap
Eris Lifesciences has a market cap or net worth of 201.21 billion as of January 14, 2026. Its market cap has increased by 9.23% in one year.
Market Cap
201.21B
Enterprise Value
228.47B
Revenue
29.86B
Ranking
n/a
PE Ratio
48.50
Stock Price
1,473.90
Market Cap Chart
Since June 29, 2017, Eris Lifesciences's market cap has increased from 82.71B to 201.21B, an increase of 143.28%. That is a compound annual growth rate of 10.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 13, 2026 | 201.21B | -1.89% |
| Dec 31, 2025 | 205.09B | 9.67% |
| Dec 31, 2024 | 187.00B | 51.07% |
| Dec 29, 2023 | 123.79B | 40.63% |
| Dec 30, 2022 | 88.02B | -14.80% |
| Dec 31, 2021 | 103.31B | 31.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.15T |
| Divi's Laboratories | 1.76T |
| Cipla | 1.18T |
| Apollo Hospitals Enterprise | 1.04T |
| Mankind Pharma | 908.50B |
| Zydus Lifesciences | 900.48B |
| Aurobindo Pharma | 696.21B |
| Alkem Laboratories | 693.36B |